6th International Nanomedicine and Drug Delivery Symposium

第六届国际纳米医学与药物输送研讨会

基本信息

项目摘要

DESCRIPTION (provided by applicant): In recent years there has been an explosive increase in activity and interest in the field of nanomedicine, which refers to the development of nanotechnologies for medical applications. Indeed, several nanomedicines have received clinical approval while others have entered clinical trial development. The three major areas of application that have emerged in this field are (1) drug delivery, (2) bioimaging, and (3) tissue engineering. The overall objective of the 6th International Nanomedicine and Drug Delivery Symposium (i.e. NanoDDS'08), which is to be held in Toronto, Canada from October 18th to 19th, 2008, is to highlight new groundbreaking discoveries and developments in the field of nanomedicine while bringing together scientists with expertise in drug delivery, bioimaging and tissue engineering. Additional specific Objectives of NanoDDS'08 are (1) to encourage discussion, sharing of information and collaboration amongst academic and industrial scientists, (2) to provide a forum to discuss issues relating to the pre-clinical and clinical development of nanomedicines, (3) to enable trainees (i.e. graduate students and post-doctoral fellows) to present their research at the international level and interact with other new promising investigators and world-renowned scientists.
描述(由申请人提供):近年来,纳米医学领域的活动和兴趣呈爆炸性增长,纳米医学指的是用于医疗应用的纳米技术的开发。事实上,一些纳米药物已获得临床批准,而其他纳米药物则已进入临床试验开发。在该领域中出现的三个主要应用领域是(1)药物递送,(2)生物成像,和(3)组织工程。第六届国际纳米医学和药物输送研讨会(即NanoDDS'08)的总体目标,将于2008年10月18日至19日在加拿大多伦多举行,是为了突出新的突破性发现和纳米医学领域的发展,同时汇集科学家与药物输送,生物成像和组织工程的专业知识。NanoDDS'08的其他具体目标是(1)鼓励学术和工业科学家之间的讨论、信息共享和合作,(2)提供一个论坛来讨论与纳米医学的临床前和临床开发有关的问题,(3)使学员(即研究生和博士后研究员)在国际一级展示他们的研究,并与其他新的有前途的研究人员和世界知名的科学家互动。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sixth International Nanomedicine and Drug Delivery Symposium (NanoDDS'08).
第六届国际纳米医学和药物输送研讨会(NanoDDS08)。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDER V KABANOV其他文献

ALEXANDER V KABANOV的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDER V KABANOV', 18)}}的其他基金

Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
用于髓母细胞瘤免疫治疗的天然靶向外泌体 TLR7/8 激动剂
  • 批准号:
    10790660
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
纳米制剂紫杉醇-铂组合的转化
  • 批准号:
    10436355
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
纳米制剂紫杉醇-铂组合的转化
  • 批准号:
    10684815
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
纳米制剂紫杉醇-铂组合的转化
  • 批准号:
    10621403
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
纳米制剂紫杉醇-铂组合的转化
  • 批准号:
    10306113
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
Diversity Supplement - TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
多样性补充 - 纳米配方紫杉醇-铂组合的转化
  • 批准号:
    10529457
  • 财政年份:
    2021
  • 资助金额:
    $ 1万
  • 项目类别:
2017 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar
2017癌症纳米技术戈登研究大会暨戈登研究研讨会
  • 批准号:
    9260177
  • 财政年份:
    2017
  • 资助金额:
    $ 1万
  • 项目类别:
Targeted Magneto-Mechanic Nanotherapeutics for Cancer
癌症靶向磁力纳米疗法
  • 批准号:
    9382042
  • 财政年份:
    2017
  • 资助金额:
    $ 1万
  • 项目类别:
Targeted Magneto-Mechanic Nanotherapeutics for Cancer
癌症靶向磁力纳米疗法
  • 批准号:
    9751229
  • 财政年份:
    2017
  • 资助金额:
    $ 1万
  • 项目类别:
Nasal Leptin - Polymer Conjugate for Treatment of Obesity
鼻瘦素 - 用于治疗肥胖的聚合物缀合物
  • 批准号:
    9140512
  • 财政年份:
    2016
  • 资助金额:
    $ 1万
  • 项目类别:

相似海外基金

Toward Effective Policy and Clinical Care in the Context of Track 2 MAID in Canada
在加拿大第二轨道 MAID 的背景下迈向有效的政策和临床护理
  • 批准号:
    488023
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Operating Grants
REACHing underserved and undiagnosed populations living with STBBIs to test and link them to care: Implementing innovative clinical trials (iCTs) designs to "test and treat" and bring new rapid point-of-care and self-tests to market in Canada
覆盖服务不足和未确诊的 STBBI 患者,对他们进行测试并将其与护理联系起来:实施创新的临床试验 (iCT) 设计来“测试和治疗”,并将新的快速护理点和自我测试推向加拿大市场
  • 批准号:
    481601
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Operating Grants
Optimizing the vaginal microbiome In African, Caribbean and other Black women from Toronto, Canada: defining clinical endpoints and community priorities
优化来自加拿大多伦多的非洲、加勒比和其他黑人女性的阴道微生物组:确定临床终点和社区优先事项
  • 批准号:
    494152
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Operating Grants
Promoting Inclusion in Clinical Trials: Understanding the participant-related barriers for new immigrants to Canada
促进临床试验的包容性:了解加拿大新移民与参与者相关的障碍
  • 批准号:
    485595
  • 财政年份:
    2023
  • 资助金额:
    $ 1万
  • 项目类别:
    Miscellaneous Programs
Canadian Critical Care Trials Group COVID-19 Response: defining critical care capacity in Canada; testing treatments through large-scale adaptive clinical trials; & establishing the evidence base to inform clinical and health system management decisions
加拿大重症监护试验组 COVID-19 响应:定义加拿大的重症监护能力;
  • 批准号:
    466020
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
    Directed Grant
Canadian Critical Care Trials Group COVID-19 Response: defining critical care capacity in Canada; testing treatments through large-scale adaptive clinical trials; & establishing the evidence base to inform clinical and health system management decisions
加拿大重症监护试验组 COVID-19 响应:定义加拿大的重症监护能力;
  • 批准号:
    465699
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
    Directed Grant
Increasing capacity for Maternal and PAediatric Clinical Trials (IMPACT) in Canada
提高加拿大孕产妇和儿科临床试验 (IMPACT) 的能力
  • 批准号:
    466180
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
    Operating Grants
Accelerating Clinical Trials (ACT) - Canada
加速临床试验 (ACT) - 加拿大
  • 批准号:
    471359
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
    Operating Grants
Accelerating Clinical Trials (ACT) - Canada
加速临床试验 (ACT) - 加拿大
  • 批准号:
    467903
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
    Operating Grants
Canada-Africa Monkeypox Partnership (CAMP): Characterizing transmission dynamics and evaluating medical countermeasures to inform the clinical and public health response to Mpox
加拿大-非洲猴痘合作伙伴关系 (CAMP):描述传播动态并评估医疗对策,为临床和公共卫生应对 Mpox 提供信息
  • 批准号:
    471053
  • 财政年份:
    2022
  • 资助金额:
    $ 1万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了